Published in Oncotarget on May 24, 2016
Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases. Oncotarget (2016) 0.77
Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network. Oncotarget (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet (2006) 16.12
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res (2010) 10.97
A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med (2007) 10.47
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol (2008) 7.35
Real-time PCR in virology. Nucleic Acids Res (2002) 6.71
Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med (2006) 6.69
The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell (2009) 6.44
Independence and reproducibility across microarray platforms. Nat Methods (2005) 6.26
The 2004 World Health Organization classification of lung tumors. Semin Roentgenol (2005) 5.23
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res (2006) 4.11
False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics (2005) 3.83
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics (2008) 3.24
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (2010) 3.21
Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res (2005) 2.97
The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg (2009) 2.96
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics (2010) 2.39
Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol (2007) 2.10
Community landscapes: an integrative approach to determine overlapping network module hierarchy, identify key nodes and predict network dynamics. PLoS One (2010) 1.74
Genetic risk factors for pancreatic disorders. Gastroenterology (2013) 1.73
Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res (1990) 1.43
The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J (2002) 1.42
Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. Mol Biol Cell (1999) 1.28
Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem (2002) 1.26
Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep (2006) 1.19
Hierarchy measure for complex networks. PLoS One (2012) 1.18
Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res (2000) 1.15
Expression, regulation, and function of the SPR family of proteins. A review. Cell Biochem Biophys (1999) 1.15
ModuLand plug-in for Cytoscape: determination of hierarchical layers of overlapping network modules and community centrality. Bioinformatics (2012) 1.14
The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis. J Biol Chem (2001) 1.10
Management of early-stage lung cancer: past, present, and future adjuvant trials. Oncology (Williston Park) (2006) 1.06
Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis. Genes Chromosomes Cancer (2011) 1.03
Network-based tools for the identification of novel drug targets. Sci Signal (2011) 1.03
Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol (2005) 1.01
Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin Cancer Res (2007) 0.99
Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis. Pathobiology (2004) 0.91
Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Jpn J Clin Oncol (2010) 0.90
CLCA2 as a p53-inducible senescence mediator. Neoplasia (2012) 0.89
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecol Oncol (2012) 0.89
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients. Clin Cancer Res (1999) 0.88
Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer. Clin Cancer Res (2008) 0.88
AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer. J Int Med Res (2011) 0.88
Ranking analysis of F-statistics for microarray data. BMC Bioinformatics (2008) 0.84
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance. Clin Cancer Res (2009) 0.84
PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma. Biomed Res Int (2013) 0.81
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol (2002) 0.81
TFF1 inhibits proliferation and induces apoptosis of gastric cancer cells in vitro. Bosn J Basic Med Sci (2012) 0.80
Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Eur J Cancer (1994) 0.80
SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle. Am J Physiol Lung Cell Mol Physiol (2003) 0.79
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma. Int J Biol Markers (2002) 0.79
Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death. Cell Death Dis (2014) 0.79
An approach for optimally extending mathematical models of signaling networks using omics data. Conf Proc IEEE Eng Med Biol Soc (2015) 0.76
A small proline-rich protein regulated by vitamin A in tracheal epithelial cells is induced in lung tumors. Am J Respir Cell Mol Biol (1993) 0.76
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: an experimental study. Eur J Cardiothorac Surg (2016) 0.82
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nat Med (2017) 0.75
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma. Interact Cardiovasc Thorac Surg (2017) 0.75
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study. Oncotarget (2017) 0.75